TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is awarding the ...
Eva Ados, ERshares COO and chief investment strategist, joins CNBC's 'Power Lunch' to share outlooks on three stocks.
Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight ...
U.S. equities rose at midday on optimism the new tariffs threatened by President Trump won't be as severe as initially ...
The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready ...
The U.S. government has awarded Moderna $590 million to help speed up the development of a bird flu vaccine. President Trump ...
Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...
The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu ...
A population-based congenital cytomegalovirus screening program in Ontario successfully screened 551,034 newborns; of those ...
The support is designed to speed development of well-matched H5N1 vaccines and pave the way for vaccines against other ...
Netflix earnings after the bell drive focus in tech stocks. Dow and S&P climb as optimism over trade policy fuels market ...
Cryptocurrencies pulled back after President Trump didn't mention crypto in his inauguration address. Shares in MicroStrategy, which also disclosed it had [recently bought another $1.1 billion of bitc ...